| Literature DB >> 21859302 |
Stephanie A Robertson1, Adam R Renslo.
Abstract
The Sandler Center's approach to target-based drug discovery for neglected tropical diseases is to focus on parasite targets that are homologous to human targets being actively investigated in the pharmaceutical industry. In this way we attempt to use both the know-how and actual chemical matter from other drug-development efforts to jump start the discovery process for neglected tropical diseases. Our approach is akin to drug repurposing, except that we seek to repurpose leads rather than drugs. Medicinal chemistry can then be applied to optimize the leads specifically for the desired antiparasitic indication.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21859302 PMCID: PMC3199145 DOI: 10.4155/fmc.11.85
Source DB: PubMed Journal: Future Med Chem ISSN: 1756-8919 Impact factor: 3.808